Diagnostics & Research
The Diagnostics & Research industry has a total of 51 stocks, with a combined market cap of $797.29 billion, total revenue of $166.27 billion and a weighted average PE ratio of 53.57.
Market Cap
797.29B
Revenue
166.27B
Profits
14.88B
PE Ratio
53.57
Profit Margin
8.95%
Dividend Yield
0.18%
51 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 220.72B | 2.57% | 1,933,565 | 43.74B |
| 2 | DHR | Danaher Corporation | 160.62B | 2.34% | 3,181,316 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 57.96B | 5.30% | 972,621 | 4.17B |
| 4 | A | Agilent Technologies, Inc. | 42.88B | 4.27% | 2,469,168 | 6.79B |
| 5 | IQV | IQVIA Holdings Inc. | 38.30B | 3.59% | 1,446,612 | 15.90B |
| 6 | NTRA | Natera, Inc. | 31.83B | 2.25% | 2,871,365 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 29.67B | 3.78% | 293,092 | 3.94B |
| 8 | WAT | Waters Corporation | 23.46B | 4.06% | 596,624 | 3.11B |
| 9 | LH | Labcorp Holdings Inc. | 22.02B | 1.59% | 1,091,505 | 13.77B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.28B | 1.94% | 1,769,771 | 10.85B |
| 11 | EXAS | Exact Sciences Corporation | 19.12B | 0.23% | 19,380,266 | 3.08B |
| 12 | ILMN | Illumina, Inc. | 18.92B | 3.85% | 2,371,951 | 4.29B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.67B | 0.97% | 253,164 | 2.36B |
| 14 | GH | Guardant Health, Inc. | 13.29B | 5.10% | 3,348,398 | 902.57M |
| 15 | ICLR | ICON Public Limited Company | 12.57B | 4.07% | 1,336,906 | 8.10B |
| 16 | RVTY | Revvity, Inc. | 11.14B | 4.52% | 1,564,009 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 10.16B | 2.56% | 830,515 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 8.25B | 3.43% | 1,342,710 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 6.40B | 4.72% | 1,162,356 | 1.97B |
| 20 | BLLN | BillionToOne, Inc. | 4.92B | 14.97% | 209,784 | 209.03M |
| 21 | SHC | Sotera Health Company | 4.64B | 3.42% | 2,337,454 | 1.15B |
| 22 | WGS | GeneDx Holdings Corp. | 4.24B | 9.29% | 768,863 | 402.19M |
| 23 | GRAL | GRAIL, Inc. | 3.65B | 9.22% | 1,988,963 | 141.83M |
| 24 | VCYT | Veracyte, Inc. | 3.48B | 7.74% | 1,185,505 | 495.14M |
| 25 | TWST | Twist Bioscience Corporation | 1.75B | 9.55% | 2,609,740 | 376.57M |
| 26 | NEO | NeoGenomics, Inc. | 1.49B | 8.30% | 2,606,662 | 709.16M |
| 27 | NEOG | Neogen Corporation | 1.24B | 5.73% | 4,810,762 | 886.89M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.11B | 6.05% | 727,792 | 343.53M |
| 29 | OPK | OPKO Health, Inc. | 1.01B | 1.54% | 3,298,881 | 642.07M |
| 30 | FLGT | Fulgent Genetics, Inc. | 927.37M | 4.24% | 321,275 | 315.55M |
| 31 | CDNA | CareDx, Inc | 883.61M | 9.01% | 797,319 | 358.00M |
| 32 | PSNL | Personalis, Inc. | 864.07M | 17.51% | 1,951,516 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 687.92M | 6.96% | 1,449,283 | 825.30M |
| 34 | PRE | Prenetics Global Limited | 213.38M | -1.55% | 68,816 | 77.08M |
| 35 | IMDX | Insight Molecular Diagnostics Inc. | 173.13M | -0.49% | 67,299 | 4.40M |
| 36 | XGN | Exagen Inc. | 172.47M | -2.06% | 219,876 | 63.60M |
| 37 | MDXH | MDxHealth SA | 164.33M | 2.15% | 137,869 | 103.07M |
| 38 | BNR | Burning Rock Biotech Limited | 153.42M | -8.24% | 67,519 | 75.75M |
| 39 | FONR | FONAR Corporation | 93.62M | -0.63% | 17,726 | 105.43M |
| 40 | BDSX | Biodesix, Inc. | 54.34M | 4.92% | 26,079 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 42.92M | -4.37% | 6,844 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 28.25M | -3.89% | 740,367 | 505.30M |
| 43 | BNBX | BNB Plus Corp. | 10.58M | -2.80% | 62,973 | 3.74M |
| 44 | PRPH | ProPhase Labs, Inc. | 8.73M | -1.46% | 1,280,293 | 5.06M |
| 45 | ADVB | Advanced Biomed Inc. | 8.03M | -1.70% | 118,359 | - |
| 46 | CHEK | Check-Cap Ltd. | 7.61M | -3.70% | 51,066 | - |
| 47 | BIAF | bioAffinity Technologies, Inc. | 6.60M | 6.52% | 229,351 | 6.78M |
| 48 | MYNZ | Mainz Biomed N.V. | 5.41M | -5.75% | 289,949 | 659.94K |
| 49 | NDRA | ENDRA Life Sciences Inc. | 5.02M | -23.76% | 80,745 | - |
| 50 | XWEL | XWELL, Inc. | 4.33M | -1.06% | 26,410 | 29.52M |
| 51 | ISPC | iSpecimen Inc. | 4.16M | 1.21% | 123,435 | 3.35M |